nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

18.06.2016 | Original Article – Clinical Oncology

Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?

verfasst von: Andrea Papadia, Sara Imboden, Maria Luisa Gasparri, Franziska Siegenthaler, Anja Fink, Michael D. Mueller

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The adoption of a sentinel lymph node (SLN) algorithm and the presence of high bilateral detection rates have been associated with increased accuracy of SLN mapping in cervical and endometrial cancer patients. In this context, the significance of the number of SLNs removed has not yet been investigated. The aim of this study was to evaluate (a) whether or not a higher SLN removal count is associated with a reduced false-negative rate and (b) which clinical factors correlate with the number of SLNs removed.

Methods

Patients with cervical or endometrial cancer who underwent SLN mapping with bilateral SLN detection followed by lymphadenectomy were evaluated retrospectively. On the basis of the mean number of the SLNs removed, the patients were divided in two groups: Group 1 included patients with up to 3 SLNs removed and Group 2 included patients with more than 3 SLNs removed. Factors predicting a higher SLN count were evaluated using univariate and multivariate analysis.

Results

Eighty-four patients met the inclusion criteria. The two groups consisted of 42 patients each and differed only by the median SLN count. Two endometrial cancer patients in Group 1 had false-negative pelvic SLNs and isolated para-aortic metastases; no false-negative SLNs were recorded in Group 2 (p = n.s.). The results of multivariate analysis indicted that the number of SLNs removed was influenced only in cases where the operating surgeon had performed more than 20 laparoscopic ICG SLN mappings.

Conclusions

A higher SLN count does not seem to increase the accuracy of SLN mapping in cervical and endometrial cancer patients.

ASTEC Study Group, Kitchener H, Swart AM, Quian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125–136CrossRef

Barlin JN, Khoury-Collado F, Kim CH, Leitao MM, Chi DS, Sonoda Y et al (2012) The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol 125:531–535CrossRefPubMed

Benedetti Panici P, Basile S, Maneschi F, Lissoni A, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707–1716CrossRefPubMed

Bogani G, Ditto A, Martinelli F, Signorelli M, Perotto S, Lorusso D et al (2015) A critical assessment on the role of sentinel node mapping in endometrial cancer. J Gynecol Oncol. 26:252–254CrossRefPubMedPubMedCentral

Buda A, Papadia A, Zapardiel I, Vizza E, Ghezzi F, De Ponti E et al (2016) From conventional radiotracer Tc-99-m with blue dye to indocyanine green fluorescence: a comparison of methods towards optimization of sentinel lymph node mapping in early stage cervical cancer for a laparoscopic approach. Ann Surg Oncol PMID: 27126631

Chagpar AB, Scoggins CR, Martin RC, Carlson DJ, Laidley AL, El-Eid SE et al (2007) Are 3 sentinel nodes sufficient? Arch Surg 142:456–460CrossRefPubMed

Colombo N, Creutzberg C, Amant F, Bosse T, Gonzaléz-Martin A, Lederman J, Marth C et al (2016) ESMO-ESGO-ESTRO consensus conference on endometiral cancer diagnosis, treatment and follow up. Int J Gynaecol Cancer 26:2–30CrossRef

Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F (1990) Prospective surgical-pathological study of disease-free interval on patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38:352–357CrossRefPubMed

Ditto A, Martinelli F, Bogani G, Gasparri ML, Di Donato V, Zanaboni F et al (2015a) Implementation of laparoscopic approach for type B radical hysterectomy: a comparison with open surgical operations. Eur J Surg Oncol 41:34–39CrossRefPubMed

Ditto A, Martinelli F, Bogani G, Papadia A, Lorusso D, Raspagliesi F (2015b) Sentinel node mapping using hysteroscopic injection of indocyanine green and laparoscopic near-infrared fluorescence imaging in endometrial cancer staging. J Minim Invasive Gynecol 22:132–133CrossRefPubMed

Goyal A, Newcombe RG, Chhabra A, Mansel RE, ALMANAC Trialist Group (2006) Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203–208CrossRefPubMed

How J, Gotlieb WH, Press JZ, Abitbol J, Pelmus M, Ferenczy A et al (2015) Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecol Oncol 137:436–442CrossRefPubMed

Imboden S, Papadia A, Nauwerk M, McKinnon B, Kollman Z, Mohr S et al (2015) A comparison of radiocolloid and indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with cervical cancer undergoing laparoscopic surgery. Ann Surg Oncol 22:4198–4203CrossRefPubMedPubMedCentral

Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC et al (2012) A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol 127:525–531CrossRefPubMed

Kumar S, Podratz KC, Bakkum-Gamez JN, Dowdy SC, Weaver AL, McGree ME et al (2014) Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol 132:38–43CrossRefPubMed

Laufer J, Scasso S, Papadia A, Sosa C, Cirillo F, Raspagliesi F (2013) Association between tumor diameter and lymphovascular space invasion among women with early-stage endometrial cancer. Int J Gynaecol Obstet 123:142–145CrossRefPubMed

Martin RC, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, Brown CM et al (2000) Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multiinstitutional study. Surgery 128:139–144CrossRefPubMed

McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS (2001) The breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 192:692–697CrossRefPubMed

McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD et al (2001) Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 234:292–300CrossRefPubMedPubMedCentral

Morotti M, Menada MV, Moioli M, Sala P, Maffeo I, Abete L et al (2012) Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Gynecol Oncol 125:536–540CrossRefPubMed

Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE et al (1999) Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230:453–463CrossRefPubMedPubMedCentral

Papadia A, Remorgida V, Salom Ragni N (2004) Laparoscopic lymphadenectomy in gynecologic oncology: a review. J Am Assoc Gynecol Laparosc 11:297–306CrossRefPubMed

Papadia A, Azioni G, Brusacà B, Fulcheri E, Nishida K, Menoni S et al (2009) Frozen section underestimates the need for surgical staging in endometrial cancer patients. Int J Gynecol Cancer 19:1570–1573CrossRefPubMed

Papadia A, Imboden S, Siegenthaler F, Gasparri ML, Mohr S, Lanz S et al (2016) Laparoscopic Indocyanine green sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol 23:2206–2211 CrossRefPubMedPubMedCentral

Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613PubMed

Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J et al (2016) Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes—a meta-analysis. Ann Surg Oncol PMID

Sala P, Morotti M, Menada MV, Cannavino E, Maffeo I, Abete L et al (2014) Intraoperative frozen section risk assessment accurately tailors the surgical staging in patients affected by early-stage endometrial cancer: the application of 2 different risk algorithms. Int J Gynecol Cancer 24:1021–1026CrossRefPubMed

Simpkins F, Papadia A, Kunos C, Michener C, Frasure H, AbuShahin F et al (2013) Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. Int J Gynecol Cancer 23:98–104CrossRefPubMed

Tanner EJ, Sinno AK, Stone RL, Stone RL, Levinson KL, Long KC et al (2015) Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. Gynecol Oncol 138:542–547CrossRefPubMed

Vaidya JS, Dewar JA, Brown DC, Thompson AM (2005) A mathematical model for the effect of a false-negative sentinel node biopsy on breast cancer mortality: a tool for everyday use. Breast Cancer Res 7:225–227CrossRefPubMedPubMedCentral

Van der Zee AG, Oonk MH, De Hullu JA, Ansink JA, Vergote I, Verheijen RH, Maggioni A et al (2008) Sentinel node dissection is safe in the treatment of early stage vulvar cancer. J Clin Oncol 26:884–889CrossRefPubMed

Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553CrossRefPubMed

Version 2.2015: NCCN Clinical Practice Guidelines in Oncology

Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS et al (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic Oncology Group Study LAP2. J Clin Oncol 27:5331–5336CrossRefPubMedPubMedCentral

Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491–500CrossRefPubMed

Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ et al (2001) Sentinel lymph node biopsy for breast cancer: impact on the number of sentinel lymph nodes removed on the false negative rate. J Am Coll Surg 192:684–689CrossRefPubMed

Woznick A, Franco M, Bendick P, Benitez PR (2006) Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg 191:330–333CrossRefPubMed

Zakaria S, Degnim AC, Kleer CG, Diehl KA, Cimmino VM, Chang AE et al (2007) Sentinel lymph node biopsy for breast cancer: how many lymph nodes are enough? J Surg Oncol 96:554–559CrossRefPubMed

Titel: Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?
verfasst von: Andrea Papadia
Sara Imboden
Maria Luisa Gasparri
Franziska Siegenthaler
Anja Fink
Michael D. Mueller
Publikationsdatum: 18.06.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-016-2193-5

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough?

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma

The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma

Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis

Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis

Mucin carriers of TF in ovarian cancer

Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie